ACE2 and diabetic retinopathy: Verma et al. have developed a probiotic engineering technique, binding human ACE2 with L. paracasei, and have successfully reduced the number of acellular capillaries, blocked retinal ganglion cell loss, and decreased retinal inflammatory cytokine expression in two mouse models of diabetic retinopathy [78].